Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2026-03-01 @ 10:11 AM
Study NCT ID:
NCT00772668
Status:
TERMINATED
Last Update Posted:
2017-12-11
First Post:
2008-10-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL
Sponsor:
University of Miami
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
20070963
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None